Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Fillit

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Improving dementia care: the role of screening and detection of cognitive impairmentSoo Borson, Lori Frank, Peter J Bayley, et al.
Brain : a Journal of Neurology|June 19, 2021
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's diseaseDawn C Matthews, Xiangling Mao, Kathleen Dowd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2016
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery FoundationHeather M Snyder, Tim Ahles, Stuart Calderwood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2021
Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemicEmily A Meyers, Philippe Amouyel, Diane E Bovenkamp, et al.
Alzheimer'S Research & Therapy|November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultationAnne Corbett, Janet Sultana, Kate Stych, et al.
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Methodological issues in primary prevention trials for neurodegenerative dementiaSandrine Andrieu, Nicola Coley, Paul Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 10, 2022
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trialsJessica B Langbaum, Julie Zissimopoulos, Rhoda Au, et al.
Innovation in Aging|May 23, 2022
Investing in Late-Life Brain CapitalWalter D Dawson, Erin Smith, Laura Booi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 10, 2012
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug developmentAdam L Boxer, Michael Gold, Edward Huey, et al.
Molecular Psychiatry|October 26, 2020
A Brain Capital Grand Strategy: toward economic reimaginationErin Smith, Diab Ali, Bill Wilkerson, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Improving dementia care: the role of screening and detection of cognitive impairmentSoo Borson, Lori Frank, Peter J Bayley, et al.
Brain : a Journal of Neurology|June 19, 2021
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's diseaseDawn C Matthews, Xiangling Mao, Kathleen Dowd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2016
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery FoundationHeather M Snyder, Tim Ahles, Stuart Calderwood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2021
Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemicEmily A Meyers, Philippe Amouyel, Diane E Bovenkamp, et al.
Alzheimer'S Research & Therapy|November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultationAnne Corbett, Janet Sultana, Kate Stych, et al.
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Methodological issues in primary prevention trials for neurodegenerative dementiaSandrine Andrieu, Nicola Coley, Paul Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 10, 2022
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trialsJessica B Langbaum, Julie Zissimopoulos, Rhoda Au, et al.
Innovation in Aging|May 23, 2022
Investing in Late-Life Brain CapitalWalter D Dawson, Erin Smith, Laura Booi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 10, 2012
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug developmentAdam L Boxer, Michael Gold, Edward Huey, et al.
Molecular Psychiatry|October 26, 2020
A Brain Capital Grand Strategy: toward economic reimaginationErin Smith, Diab Ali, Bill Wilkerson, et al.
Pageof 8